Glioma/Brain Tumor 3D Invasion Assay

• Glioma or GBM cells are used to generate multicellular spheroids; reported models include U87, U251, DBTRG, C6, LN18, LN229, and glioblastoma stem-like cells^{[2][3][4][5][7]}.

• Cell culture medium, fetal bovine serum, antibiotics, PBS, trypsin-EDTA, methylcellulose, collagen I, Matrigel, and hyaluronic acid are used for cell maintenance, spheroid formation, transfer, and 3D matrix embedding; one brain-stiffness-mimicking matrix used 0.5 mg/mL collagen I, 3 mg/mL Matrigel, and 3.3 mg/mL hyaluronic acid^[3].

• Calcein-AM and propidium iodide were used to assess live/dead cells in GBM spheroids; HIF-1α and Ki-67 staining were used to evaluate hypoxia and proliferative gradients; fluorescent labeling such as GFP expression or red-emitting membrane dyes was used to visualize tumor cells in brain-slice invasion assays^[3][6][7].

• Reported equipment includes tissue-culture incubators, low-attachment or hanging-drop culture formats, inverted brightfield microscopes, live-cell imaging systems, high-content imaging systems, confocal microscopes, fluorescence microscopes, tissue slicers for organotypic brain slices, and ImageJ-based analysis workflows^{[1][2][3][6][7]}.

• Prepare glioma or GBM spheroids using a literature-supported spheroid method such as hanging drops, liquid overlay, low-attachment plates, agarose microwells, or scaffold-free spheroid culture; hanging-drop studies used 20 µL drops, and reported starting densities ranged from 2,500-20,000 cells/20 µL in Wang et al. and up to 45,000 cells/drop in Del Duca et al. ^[3][4].

• For the Wang et al. GBM spheroid model, dilute DBTRG or U251 cells to 2,500, 5,000, 10,000, or 20,000 cells/20 µL in medium containing 0.24% methylcellulose, place 20 µL drops on a 24-well plate lid, add PBS to reduce evaporation, invert the plate, and culture at 37°C with 5% CO₂ for up to 72 h^[3].

• For matrix preparation, use the matrix formulation supported by the specific experimental goal: Matrigel alone has been used for glioblastoma stem-cell invasion with SDF-1α stimulation, collagen I or collagen I/Matrigel has been used for spheroid invasion, and collagen I/Matrigel/hyaluronic acid has been used to approximate brain extracellular matrix composition and stiffness in GBM spheroid invasion analysis^[1][2][3][5].

• Transfer formed spheroids gently into the selected 3D matrix, allow the matrix to gel under the conditions reported for that matrix system, and image invasion over time; reported imaging windows include 60 h high-content imaging in the brain-stiffness-mimicking GBM model and live-cell imaging of U87 and U251 spheroids to follow migration dynamics and drug responses^[2][3].

• For the brain-stiffness-mimicking GBM assay, embed DBTRG or U251 spheroids in 0.5 mg/mL collagen I, 3 mg/mL Matrigel, and 3.3 mg/mL hyaluronic acid, then acquire high-content images over 60 h and quantify invasion distance, invasion area, single-cell velocity, and directionality^[3].

• For an organotypic brain-slice assay, implant fluorescently labeled glioma or GBM spheroids onto adult or murine organotypic brain slices and quantify invasion by fluorescence or confocal microscopy; Eisemann et al. quantified average cumulative sprout length per spheroid, while Decotret et al. used Z-direction sectioning and the BraInZ ImageJ macro to distinguish migration on top of the slice from invasion into the brain tissue^[6][7].

• Analyze invasion from baseline-normalized images by measuring the increase in invaded area, radial invasion distance, migration index, single-cell velocity, directionality, cumulative sprout length, or Z-direction particle distance depending on the assay format^{[1][2][3][6][7]}.

• Use non-invasive or lower-invasive controls when reported in the same model; Wang et al. compared DBTRG with U251 and confirmed higher DBTRG invasion in both 3D matrix and transwell assays, while Hira et al. used SDF-1α as a chemoattractant condition to increase glioblastoma stem-cell invasion in 2D and 3D assays^[3][5].

• Interpret matrix-only spheroid invasion and brain-slice invasion separately because Decotret et al. observed that GBM spheroids invading Matrigel showed diffuse sheet-like collective invasion, whereas brain-slice invasion included single cells and strand-like structures in the tissue^[7].

Problem: Spheroids are variable in size or not uniformly formed.

• Possible cause: Initial cell number and spheroid-generation format affect spheroid size and reproducibility.
• Literature-supported solution: Use a defined starting cell number and a standardized spheroid method such as hanging drops or agarose microwells; reported hanging-drop densities include 2,500-20,000 cells/20 µL for DBTRG/U251 and 45,000 cells/drop for several brain tumor cell lines^[3][4].

Problem: Spheroids develop central necrosis before invasion analysis.

• Possible cause: Extended spheroid culture can generate necrotic cores.
• Literature-supported solution: In the Wang et al. GBM model, spheroids were generated for 72 h before invasion analysis, while necrotic cores began to appear from day 4 after spheroid formation^[3].

Problem: Brain-slice imaging fails to distinguish surface migration from true tissue invasion.

• Possible cause: Top-down imaging has limited resolution for invasion into the Z-axis of the slice.
• Literature-supported solution: Embed stained slices in agar, re-section in the Z-direction, image by confocal microscopy, and quantify invasion using a Z-direction analysis workflow such as BraInZ^[7].

Problem: Fluorescent tumor-cell signal is weak in organotypic brain slices.

• Possible cause: Tissue opacity reduces epi-fluorescence visualization.
• Literature-supported solution: Use a red-emitting membrane dye together with tissue clearing, which Eisemann et al. reported improved epi-fluorescence imaging^[6].